2024 Controversies in Hematologic Malignancies Symposium
This one-day symposium will raise and address the most challenging questions in current clinical practice for hematologic malignancy. Topics will include navigating frontline therapies in DLBCL, Clonal Hematopoiesis, transfusion medicine, immunotherapies in myeloma, BiTE Lymphoma treatment, and much more.
Target Audience
Physicians, Physician Assistants, Nurse Practitioners, Registered Nurses and Allied Health Professionals
Learning Objectives
Participants who engage in this educational intervention will be able to:
- Examine bispecific antibody treatments for Non-Hodgkin Lymphoma.
- Describe recommendations designed to improve immunotherapy treatment of multiple myeloma based on current advancements and trial results.
- Identify the role of allogenic hematopoietic stem cell transplant for higher-risk MDS.
7:30 - 8:25 a.m. View Exhibits/Breakfast
8:25 – 8:30 a.m. Introduction
Leukemia Block:
8:30 – 8:50 a.m. Myeloid Classification in 2024 – Alexandra Harrington
8:50 – 9:30 a.m. Clonal Hematopoiesis – Uma Borate
9:30 – 9:45 a.m. Panel Q&A with Presenters
9:45 – 10:00 a.m. Break
Myeloma Block:
10:00 – 10:20 a.m. Management of Newly Diagnosed Myeloma – Othman Akhtar
10:20 – 11:00 a.m. Update on CAR T-Cells and Bispecific Antibody Therapy of Myeloma – Larry Anderson
11:00 – 11:15 a.m. Panel Q&A with Presenters
11:15 – 11:30 a.m. Break
Breakout Sessions
11:30 a.m. – 12:00 p.m. Navigating the Bermuda Triangle of Transfusion Medicine & the Oncology Patient – Angela Treml
Taking a "BiTE" Out of Bispecific Antibodies in Lymphoma: Applications for Treatment Implementation – Emilie Aschenbrenner
12:00 p.m. – 12:45 p.m. Lunch
Lymphoma Block:
12:45 – 1:05 p.m. Frontline DLBCL - Sumana Devata
1:05 – 1:45 p.m. Bispecific Therapy in Lymphomas - Sonali Smith
1:45 – 2:00 p.m. Panel Q&A with Presenters
Name | Company | Role |
---|---|---|
Emilie Aschenbrenner, PharmD, BCOP | AbbVie, Genmab | Speaker |
Sonali M. Smith, MD | Genmab, Gilead, Ono Pharmaceuticals | Consultant |
Uma Borate, MD, MSc | AbbVie, Incyte, Jazz Pharmaceuticals, Pfizer, RUNX1 Foundation Genentech, Agios, Novartis, Blueprint, Astellas, Takeda, Kura, Servier | Researcher Advisory Commitee |
Larry Anderson, MD | Janssen, Celgene, Bristol Myers Squibb, Amgen, GSK, AbbVie, BeiGene, Cellectar, Sanofi BMS, Celgene, AbbVie, and Janssen | Consultant Researcher |
Available Credit
- 4.25 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 4.25 Hours of ParticipationHours of Participation credit.